Rigel Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Rigel Pharmaceuticals patents 117 in total

Status Patent
Application
Utility: COMPOUNDS AND METHOD FOR TREATING CYTOKINE RELEASE SYNDROME External link
Filling date: 26 Sep 2025 Issue date: 11 Aug 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 9 Aug 2022
Application
Utility: COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES External link
Filling date: 26 Sep 2025 Issue date: 14 Jul 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: Pyrazole compounds and methods for making and using the compounds External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Application
Utility: BENZAZOLE COMPOUNDS AND METHODS FOR MAKING AND USING THE COMPOUNDS External link
Filling date: 26 Sep 2025 Issue date: 16 Jun 2022
Grant
Utility: TGF-beta inhibitors External link
Filling date: 26 Sep 2025 Issue date: 7 Jun 2022
Application
Utility: METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME External link
Filling date: 26 Sep 2025 Issue date: 19 May 2022
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 17 May 2022
Grant
Utility: Benzazole compounds and methods for making and using the compounds External link
Filling date: 26 Sep 2025 Issue date: 12 Apr 2022
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY External link
Filling date: 26 Sep 2025 Issue date: 31 Mar 2022
Application
Utility: DIRECT AMPK ACTIVATORS External link
Filling date: 26 Sep 2025 Issue date: 31 Mar 2022
Grant
Utility: Nrf2 activating compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 22 Mar 2022
Application
Utility: METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS External link
Filling date: 26 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY External link
Filling date: 26 Sep 2025 Issue date: 27 Jan 2022
Grant
Utility: Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds External link
Filling date: 26 Sep 2025 Issue date: 25 Jan 2022
Grant
Utility: Prodrugs of 2,4-pyrimidinediamine compounds and their uses External link
Filling date: 26 Sep 2025 Issue date: 25 Jan 2022
Application
Utility: RIP1K INHIBITORS External link
Filling date: 26 Sep 2025 Issue date: 13 Jan 2022
Grant
Utility: Compounds and method for treating autoimmune diseases External link
Filling date: 26 Sep 2025 Issue date: 11 Jan 2022
Application
Utility: METHOD AND COMPOSITION EMBODIMENTS FOR TREATING ACUTE MYELOID LEUKEMIA External link
Filling date: 26 Sep 2025 Issue date: 6 Jan 2022
Grant
Utility: Compositions and methods for inhibition of the JAK pathway External link
Filling date: 26 Sep 2025 Issue date: 14 Dec 2021
Application
Utility: ACVR2A-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF External link
Filling date: 26 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER External link
Filling date: 26 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: Compositions and methods for inhibition of the JAK pathway External link
Filling date: 26 Sep 2025 Issue date: 16 Nov 2021
Grant
Utility: Direct AMPK activators External link
Filling date: 26 Sep 2025 Issue date: 16 Nov 2021
Application
Utility: RIP1K INHIBITORS External link
Filling date: 26 Sep 2025 Issue date: 14 Oct 2021
Application
Utility: KINASE INHIBITORS AND METHODS FOR MAKING AND USING External link
Filling date: 26 Sep 2025 Issue date: 7 Oct 2021
Grant
Utility: Fumarate analogs and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 28 Sep 2021
Application
Utility: METHOD FOR TREATMENT OF COVID-19-ASSOCIATED CONDITIONS External link
Filling date: 26 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: TGF- INHIBITORS External link
Filling date: 26 Sep 2025 Issue date: 9 Sep 2021
Grant
Utility: Tyrosine kinase inhibitors External link
Filling date: 26 Sep 2025 Issue date: 7 Sep 2021
Application
Utility: 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES External link
Filling date: 26 Sep 2025 Issue date: 2 Sep 2021
Grant
Utility: ACVR2A-specific antibody and method of treatment of muscle atrophy External link
Filling date: 26 Sep 2025 Issue date: 31 Aug 2021
Application
Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME External link
Filling date: 26 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME External link
Filling date: 26 Sep 2025 Issue date: 15 Jul 2021
Application
Utility: AMIDE COMPOUNDS AND METHOD FOR MAKING AND USING External link
Filling date: 26 Sep 2025 Issue date: 15 Jul 2021
Grant
Utility: Kinase inhibitors and methods for making and using External link
Filling date: 26 Sep 2025 Issue date: 13 Jul 2021
Application
Utility: IRAK INHIBITORS AND METHOD FOR MAKING AND USING External link
Filling date: 26 Sep 2025 Issue date: 17 Jun 2021
Grant
Utility: TGF- inhibitors External link
Filling date: 26 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: 2,4-pyrimidinediamine compounds and their uses External link
Filling date: 26 Sep 2025 Issue date: 18 May 2021
Application
Utility: HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS External link
Filling date: 26 Sep 2025 Issue date: 13 May 2021
Application
Utility: TGF- INHIBITORS External link
Filling date: 26 Sep 2025 Issue date: 6 May 2021
Grant
Utility: RIP1 inhibitory compounds and methods for making and using the same External link
Filling date: 26 Sep 2025 Issue date: 13 Apr 2021
Application
Utility: TYROSINE KINASE INHIBITORS External link
Filling date: 26 Sep 2025 Issue date: 18 Mar 2021
Application
Utility: Nrf2 Activating Compounds and Uses Thereof External link
Filling date: 26 Sep 2025 Issue date: 18 Mar 2021
Grant
Utility: Amide compounds and method for making and using External link
Filling date: 26 Sep 2025 Issue date: 16 Mar 2021
Application
Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME External link
Filling date: 26 Sep 2025 Issue date: 11 Mar 2021

Showing 1 to 50 of 117 patents.